by nikki mann | Sep 21, 2022 | News
We are delighted to announce that Alexandra Huener has joined the Milner team as the Head of Entrepreneurship. This exciting new role has been created to lead our expanding initiatives for entrepreneurs here in Cambridge, through the Milner Frame Shift bio-incubator,...
by nikki mann | Sep 5, 2022 | News
The Milner team enjoyed an institute visit with a difference last week, as we welcomed a group of children for Inflammatory Bowel Disease (IBD) Patient Day. The day — organised by Milner collaborator Dr Matthias Zilbauer and the Wellcome MRC Cambridge Stem Cell...
by nikki mann | Aug 3, 2022 | News
Our first ever hybrid Therapeutics Symposium was held at the end of June and we were thrilled to welcome over 350 delegates at West Road Concert Hall, with a further 200+ delegates opting to view the talks via the online symposium platform! A selection of photographs...
by nikki mann | Jul 15, 2022 | News
CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to combat cardiovascular diseases using artificial intelligence (AI). CardiaTec is developing a target discovery platform for analysing...
by nikki mann | Jul 7, 2022 | News
The CEO Today Business Women of the Year Awards 2022 edition has been published this week, and we’re delighted that Milner Deputy Director Kathryn Chapman has been announced as an awardee. Dedicated to recognising the achievements of today’s female leaders and...
by nikki mann | May 26, 2022 | News
We are thrilled to announce that the Milner collaboration with the medical research charity LifeArc has been expanded into a 5-year strategic partnership until 2026. The Milner Computational Research team, led by Namshik Han, have been collaborating closely with the...
